Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 21, 2022
- Revision received April 9, 2022
- Accepted April 11, 2022
- Published online June 23, 2022.
Copyright & Usage
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).
Author Information
- KAZUYUKI HAMADA1,2,3⇑,
- YUTARO KUBOTA1,2,3,
- YUSUKE AOKI1,2,
- NORIHIKO SUGISAWA1,2,
- JUN YAMAMOTO1,2,
- YOSHIHIKO TASHIRO1,2,
- MICHAEL BOUVET2,
- TAKUYA TSUNODA3⇑ and
- ROBERT M. HOFFMAN1,2⇑
- 1AntiCancer Inc, San Diego, CA, U.S.A.;
- 2Department of Surgery, University of California, San Diego, CA, U.S.A.;
- 3Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
- Correspondence to: Robert M. Hoffman, Ph.D., AntiCancer Inc, 7917 Ostrow St, San Diego, CA, 92111, U.S.A. Tel: +1 8586542555, Fax: +1 8582684175, e-mail: all{at}anticancer.com;
- Correspondence to: Kazuyuki Hamada, MD, Ph.D., Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan. Tel: +81 337848402, Fax: +81 337848607, e-mail: hamadakaz{at}med.showa-u.ac.jp;
- Correspondence to: Tsunoda Takuya, MD, Ph.D., Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan. Tel: +81 337848661, Fax: +81 337848661, e-mail: ttsunoda{at}med.showa-u.ac.jp